Loading...

RBC Lysis Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Red blood cell lysis buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420301 100 mL £45
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420302 500 mL £141
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride. Test

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References

(PubMed link indicates BioLegend citation)
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Zhou B, et al. 2020. Nat Immunol. 1.868055556. PubMed
  2. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  3. Asem M, et al. 2020. Cancer Res. 1156:80. PubMed
  4. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  5. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  6. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  7. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  8. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  9. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  10. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  11. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  12. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  13. Rathakrishnan A, et al. 2020. Viruses. 12: . PubMed
  14. Wang Y, et al. 2021. Cancer Res. 81:384. PubMed
  15. Wang H, et al. 2022. Nat Biomed Eng. 6:882. PubMed
  16. Yeh PY, et al. 2022. Sens Actuators B Chem. 353: . PubMed
  17. Ammothumkandy A, et al. 2022. Nat Neurosci. 25:493. PubMed
  18. Melendez E, et al. 2022. Development. 149: . PubMed
  19. Argueta LB, et al. 2022. iScience. 25:104223. PubMed
  20. Wang S, et al. 2022. Adv Sci (Weinh). 9:e2201258. PubMed
  21. Meena AS, et al. 2022. Cell Rep. 39:110937. PubMed
  22. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  23. Sugimoto S, et al. 2022. Nat Metab. 4:775. PubMed
  24. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  25. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  26. Xu Q, et al. 2022. Front Med (Lausanne). 9:940554. PubMed
  27. Alexandrou AT, et al. 2022. iScience. 25:105546. PubMed
  28. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  29. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  30. Tratwal J, et al. 2022. Front Endocrinol (Lausanne). 13:1001210. PubMed
  31. Xie Z, et al. 2022. Cell Discov. 8:133. PubMed
  32. Xiang X, et al. 2022. Medicine (Baltimore). 101:e32558. PubMed
  33. Yu Z, et al. 2023. Cancer Res. 83:700. PubMed
  34. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  35. Oh S, et al. 2023. Nat Biotechnol. :. PubMed
  36. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  37. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  38. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  39. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  40. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  41. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  42. Feng J, et al. 2022. Immunity. 55:405. PubMed
  43. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  44. Guennoun R, et al. 2022. Cancers (Basel). 14:. PubMed
  45. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  46. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  47. Wakiyama H, et al. 2022. Cancer Immunol Res. 10:1386. PubMed
  48. Roweth HG, et al. 2022. Sci Adv. 8:eabo5224. PubMed
  49. Zhong J, et al. 2022. J Adv Res. 41:145. PubMed
  50. Yun HJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  51. Daum P, et al. 2023. Front Immunol. 13:991347. PubMed
  52. Rao D, et al. 2023. Eur J Immunol. 53:e2250258. PubMed
  53. Le DT, et al. 2023. iScience. 26:106059. PubMed
  54. Romo-Rodríguez R, et al. 2023. Arch Med Res. 54:197. PubMed
  55. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  56. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  57. Chen Z, et al. 2023. Nat Commun. 14:1839. PubMed
  58. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  59. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  60. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  61. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  62. Pattnaik A, et al. 2023. Vaccines (Basel). 11:. PubMed
  63. Mulcrone PL, et al. 2023. Sci Rep. 13:8436. PubMed
  64. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  65. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  66. Matsudaira T, et al. 2023. Commun Biol. 6:665. PubMed
  67. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  68. Nguyen, H. P., An, K., et al. 2025. Nat Biotechnol. 43(12),1979-1995. PubMed
  69. Jebbawi, F., Olomski, F., et al. 2025. Allergy. 80(12),3377-3390. PubMed
  70. Xu, L., Paine, A. C., et al. 2025. J Virol. 99(10),e0126125. PubMed
  71. Haykal, T., Yang, R., et al. 2025. Cancer Res. 85(24),4995-5014. PubMed
  72. Li, S., Wang, Y., et al. 2025. Signal Transduct Target Ther. 10(1),323. PubMed
  73. Huang, H., Li, S., et al. 2025. Sci Rep. 15(1),35547. PubMed
  74. Li, Q., de Oliveira Formiga, R., et al. 2025. Nat Metab. 7(12),2510-2530. PubMed
  75. Phoon, Y. P., Wolfarth, A. A., et al. 2025. Sci Rep. 15(1),37950. PubMed
  76. Choi, Y., Shim, M., et al. 2025. Exp Mol Med. 57(11),2487-2504. PubMed
  77. Chen, Y., Liao, Y., et al. 2025. Nat Commun. 16(1),10249. PubMed
  78. Han, C., Yuan, H., et al. 2025. FASEB J. 39(23),e71273. PubMed
  79. Wessel, B. M., Castro, J. N., et al. 2025. Organoids. 4(4),0. PubMed
  80. Qiu, Z., Song, N. J., et al. 2025. J Clin Invest. 0(0),0. PubMed
  81. Lu, W., Jin, T., et al. 2025. Sci Rep. 15(1),44077. PubMed
  82. Izgutdina, A., Rashid, T., et al. 2025. J Immunother Cancer. 13(12),0. PubMed
  83. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  84. Chen Z, et al. 2020. Glia. 68:2148. PubMed
  85. Seow JJW, et al. 2021. Front Med (Lausanne). 8:603374. PubMed
  86. Shin J, et al. 2020. Hum Gene Ther. . PubMed
  87. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  88. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  89. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  90. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  91. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  92. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  93. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  94. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  95. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  96. Pracht K, et al. 2021. Eur J Immunol. 51:1089. PubMed
  97. Radwanska M, et al. 2020. Methods Mol Biol. 2116:721. PubMed
  98. Rendon CJ, et al. 2022. Front Endocrinol (Lausanne). 13:995499. PubMed
  99. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  100. Della Verde G, et al. 2022. Life Sci Alliance. 5:. PubMed
  101. Su C, et al. 2021. Front Oncol. 11:719564. PubMed
  102. Garcia-Fabiani MB, et al. 2020. STAR Protoc. :1. PubMed
  103. Zhang J, et al. 2021. Aging (Albany NY). 13:17880. PubMed
  104. Press AT, et al. 2021. EMBO Mol Med. 13:e14436. PubMed
  105. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  106. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  107. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  108. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  109. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  110. Wang J, et al. 2020. Sci Rep. 10:12785. PubMed
  111. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  112. Pietrocola F, et al. 2017. Autophagy. 0.935416667. PubMed
  113. Bikorimana JP, et al. 2022. Cell Rep Med. 3:100534. PubMed
  114. Zhang L, et al. 2022. JCI Insight. 7:. PubMed
  115. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  116. Ma H, et al. 2021. Front Immunol. 12:760095. PubMed
  117. McGill CJ, et al. 2021. STAR Protoc. 2:100948. PubMed
  118. Lutze J, et al. 2022. Methods Mol Biol. 2394:299. PubMed
  119. Hosseini A, et al. 2022. Evid Based Complement Alternat Med. 2022:5639226. PubMed
  120. Johnson CL, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H756. PubMed
  121. Stringhini M, et al. 2021. MAbs. 13:1868066. PubMed
  122. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  123. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  124. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  125. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  126. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  127. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  128. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  129. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  130. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  131. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  132. Bravo–San Pedro JM, et al. 2019. Cell Metab. 30:754. PubMed
  133. Clark EL, et al. 2017. PLoS Genet. 13:e1006997. PubMed
  134. Cantor JR, et al. 2017. Cell. 169:258. PubMed
  135. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  136. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  137. Wu Y, et al. 2021. Nat Biomed Eng. 5:1336. PubMed
  138. Meng S, et al. 2022. Exp Anim. . PubMed
  139. Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed
  140. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  141. Zhai Z, et al. 2021. Medicine (Baltimore). 100:e26214. PubMed
  142. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  143. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  144. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  145. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  146. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  147. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  148. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  149. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  150. Pokhrel RH, et al. 2022. Int J Mol Sci. 23:. PubMed
  151. Wang D, et al. 2021. Signal Transduct Target Ther. 6:376. PubMed
  152. Machado H, et al. 2021. PLoS Pathog. 17:e1009933. PubMed
  153. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  154. Singh SS, et al. 2021. Eur J Med Chem. 216:113312. PubMed
  155. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  156. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  157. Orr AN, et al. 2021. Int J Mol Sci. 22:. PubMed
  158. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  159. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  160. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  161. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  162. Jiang J, et al. 2018. Cancer Med. 3.504861111. PubMed
  163. Chen Z, et al. 2017. Cancer Res. 77:2266. PubMed
  164. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  165. Mo L, et al. 2022. Front Oncol. 12:871489. PubMed
  166. Huang L, et al. 2021. J Cell Physiol. 236:7308. PubMed
  167. Whytock KL, et al. 2022. iScience. 25:104772. PubMed
  168. Neufeld L, et al. 2021. Sci Adv. 7:. PubMed
  169. Friedman G, et al. 2020. Nat Cancer. 1:692. PubMed
  170. Kumar A, et al. 2021. Part Fibre Toxicol. 18:43. PubMed
  171. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  172. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  173. Kildisiute G, et al. 2021. Sci Adv. 7: . PubMed
  174. Schiferle EB, et al. 2021. Sci Adv. 7: . PubMed
  175. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  176. Bigenwald C, et al. 2021. Nat Med. 27:851. PubMed
  177. Gingrich AA, et al. 2021. Front Immunol. 12:670309. PubMed
  178. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  179. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  180. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  181. Patil R, et al. 2019. J Biomed Opt. 24:1. PubMed
  182. Ongaro T, et al. 2020. Oncotarget. 3.026388889. PubMed
  183. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  184. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  185. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  186. Appelbe O, et al. 2017. J Control Release.. 10.1016/j.jconrel.2017.09.043. PubMed
  187. Tang J, et al. 2017. Proc Natl Acad Sci U S A. 114:E7441. PubMed
  188. Liccardi G, et al. 2019. Mol Cell. 73:413. PubMed
  189. Qin L, et al. 2022. Nat Commun. 13:6051. PubMed
  190. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  191. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  192. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  193. Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed
  194. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  195. Choi JW, et al. 2020. PLoS One. 15:e0235518. PubMed
  196. Alban TJ, et al. 2020. Front Immunol. 1.285416667. PubMed
  197. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  198. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  199. Martínez-Muriana A, et al. 2020. Stem Cell Res Ther. 11:53. PubMed
  200. Pennig J, et al. 2019. Sci Rep. 9:17937. PubMed
  201. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  202. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  203. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  204. Evans AK, et al. 2020. Neurobiol Dis. 146:105089. PubMed
  205. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  206. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  207. Alghamri MS, et al. 2020. Methods Enzymol. 632:215. PubMed
  208. Yu Z, et al. 2021. Front Oncol. 11:659251. PubMed
  209. Deng J, et al. 2021. Nat Cancer. 2:503. PubMed
  210. Sci T 2013. Toxicol Sci. 136:72. PubMed
  211. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  212. Nwani NG, et al. 2019. Cancers (Basel). 0.806944444. PubMed
  213. Ramalingam P, et al. 2020. Nat Commun. 11:666. PubMed
  214. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  215. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  216. Kernfeld EM, et al. 2018. Immunity. 48:1258. PubMed
  217. Beaudoin-Bussières G, et al. 2022. Cell Rep. 38:110368. PubMed
  218. Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed
  219. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  220. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  221. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  222. Patel M, et al. 2021. Cancer Res. 81:3985. PubMed
  223. Shi X, et al. 2021. Nat Commun. 12:2547. PubMed
  224. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  225. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  226. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  227. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  228. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  229. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  230. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  231. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  232. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  233. Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
  234. Zhu QY, et al. 2021. Nat Commun. 12:6624. PubMed
  235. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  236. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  237. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  238. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  239. Hang J, et al. 2019. Cancer Med. 1.254166667. PubMed
  240. Tan X, et al. 2019. Sci Rep. 2.7125. PubMed
  241. Lienemann PS, et al. 2020. Adv Sci (Weinh). 7:1903395. PubMed
  242. Zhao J, et al. 2013. Elife. 21:537. PubMed
  243. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  244. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  245. Fidalgo MF, et al. 2022. Life Sci Alliance. 5:. PubMed
  246. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  247. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  248. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  249. Pace J, et al. 2022. J Biomed Opt. 27:. PubMed
  250. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  251. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  252. Castoldi F, et al. 2020. Cell Death Discov. 0.339583333. PubMed
  253. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  254. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  255. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  256. Schweppe RE, et al. 2019. Mol Cancer Res. 17:1036. PubMed
  257. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  258. Yang A, et al. 2018. Cancer Discov. 0.525. PubMed
  259. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  260. Yan Q, et al. 2022. Clin Transl Med. 12:e1084. PubMed
  261. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  262. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  263. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  264. Wang Z, et al. 2020. Cell Rep. 33:108472. PubMed
  265. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  266. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  267. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  268. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  269. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  270. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  271. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  272. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  273. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
  274. Gangwar RS, et al. 2020. Sci Rep. 10:14348. PubMed
  275. Dyck S, et al. 2018. J Neuroinflammation. 0.6875. PubMed
  276. Michelotti TC, et al. 2022. Front Cell Dev Biol. 10:1025240. PubMed
  277. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  278. Hollerbach A, et al. 2021. J Thromb Haemost. . PubMed
  279. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  280. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  281. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  282. Majumdar D, et al. 2021. Curr Protoc. 1:e216. PubMed
  283. Zhang J, et al. 2020. Pain. 161:1381. PubMed
  284. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  285. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  286. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  287. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  288. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  289. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  290. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  291. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  292. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  293. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
  294. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  295. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  296. Xiang Y, et al. 2022. Skelet Muscle. 12:19. PubMed
  297. Yamazaki T, et al. 2021. Oncoimmunology. 10:1962592. PubMed
  298. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  299. Tulasi DY, et al. 2021. Cell Mol Gastroenterol Hepatol. 11:1437. PubMed
  300. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  301. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  302. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  303. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  304. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  305. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  306. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  307. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  308. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  309. James M, et al. 2017. J Nucl Med. . 10.2967/jnumed.117.189597. PubMed
  310. Annibaldi A, et al. 2018. Mol Cell. 69:566. PubMed
  311. Hill SJ, et al. 2018. Cancer Discov. 1.308333333. PubMed
  312. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  313. Xue X, et al. 2021. Cent Eur J Immunol. 46:191. PubMed
  314. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  315. Mai CL, et al. 2021. Theranostics. 11:1059. PubMed
  316. Chen P, et al. 2021. Clin Transl Med. 11:e462. PubMed
  317. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  318. Linder A, et al. 2020. EMBO J. 39:e105071. PubMed
  319. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  320. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  321. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  322. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  323. McLaughlin S, et al. 2019. Nat Commun. 3.795833333. PubMed
  324. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  325. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  326. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  327. Soileau AM, et al. 2022. Vet Sci. 9:. PubMed
  328. McClellan BL, et al. 2022. STAR Protoc. 3:101357. PubMed
  329. Governa V, et al. 2022. Proc Natl Acad Sci U S A. 119. PubMed
  330. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  331. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  332. DU T, et al. 2020. Front Immunol. 1.571527778. PubMed
  333. Trial J, et al. 2020. Geroscience. . PubMed
  334. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  335. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  336. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  337. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  338. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  339. Roh–Johnson M, et al. 2017. Dev Cell. 43:549. PubMed
  340. Müller C, et al. 2018. Elife. 7:e34985. PubMed
  341. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  342. Cordo' V, et al. 2022. Nat Commun. 13:1048. PubMed
  343. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  344. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  345. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  346. Nagree MS, et al. 2022. EMBO Mol Med. 14:e14297. PubMed
  347. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  348. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  349. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
  350. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  351. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  352. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  353. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  354. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  355. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  356. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  357. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  358. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  359. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  360. Visweshwaran SP, et al. 2022. Front Cell Dev Biol. 10:1008898. PubMed
  361. Li Q, et al. 2022. Signal Transduct Target Ther. 7:222. PubMed
  362. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  363. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  364. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  365. Cebrian-Silla A, et al. 2021. Elife. 10:. PubMed
  366. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  367. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  368. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  369. Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed
  370. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  371. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  372. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  373. Kucykowicz S, et al. 2022. STAR Protoc. 3:101356. PubMed
  374. Kim TW, et al. 2022. Mol Ther Oncolytics. 26:1. PubMed
  375. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  376. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  377. Huang N, et al. 2021. Nat Med. 27:892. PubMed
  378. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  379. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  380. Erady C, et al. 2021. NPJ Genom Med. 6:04. PubMed
  381. de Silva S, et al. 2020. Cancer Immunol Res. 0.493055556. PubMed
  382. Wan C, et al. 2021. Cancer Res. 81:158. PubMed
  383. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed
  384. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  385. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  386. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  387. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed
  388. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  389. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  390. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  391. Tomas C, et al. 2019. Sci Rep. 9:11464. PubMed
  392. Kim JK, et al. 2019. Bioengineering (Basel). 6:24. PubMed
  393. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  394. Guo P, et al. 2017. J Clin Invest. 127:4242. PubMed
  395. Tsai SC, et al. 2017. Biomicrofluidics. 11:034122. PubMed
  396. Roy IM, et al. 2021. Bio Protoc. 11:e4130. PubMed
  397. Alam A, et al. 2022. STAR Protoc. 3:101563. PubMed
  398. Xiang Y, et al. 2022. Exp Mol Med. 54:1011. PubMed
  399. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  400. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  401. Wahane S, et al. 2021. Sci Adv. 7:. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 06/10/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account